CADL - Candel Therapeutics Inc
IEX Last Trade
6.75
0.370 5.481%
Share volume: 342,735
Last Updated: Fri 30 Aug 2024 09:59:28 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.38
0.37
5.80%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-12 | 2022-08-05 | 2022-11-10 | 2023-03-30 | 2023-05-11 | 2023-08-10 | 2023-11-09 | |
| Cash flow financing | 19.916 M | 22.000 K | 0.000 | 36.000 K | 0.000 | 0.000 | 0.000 | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -8.053 M | -7.097 M | -9.384 M | -6.885 M | -10.819 M | -7.195 M | -8.808 M | |
| Net income | -874.000 K | -4.149 M | -8.688 M | -5.083 M | -8.795 M | -9.614 M | -8.435 M | |
| Depreciation | 165.000 K | 187.000 K | 205.000 K | 221.000 K | 230.000 K | 236.000 K | 245.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -171.000 K | -635.000 K | -215.000 K | -276.000 K | 19.000 K | -169.000 K | -103.000 K | |
| Net Borrowings | -72.854 M | -64.531 M | -56.262 M | -49.145 M | -39.086 M | -30.582 M | -22.330 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -171.000 K | -635.000 K | -215.000 K | -276.000 K | -138.000 K | -169.000 K | -103.000 K | |
| Cash Change | 94.321 M | 86.782 M | 77.183 M | 70.058 M | 59.258 M | 51.894 M | 42.983 M |